vs
Side-by-side financial comparison of AerSale Corp (ASLE) and Vanda Pharmaceuticals Inc. (VNDA). Click either name above to swap in a different company.
AerSale Corp is the larger business by last-quarter revenue ($90.9M vs $57.2M, roughly 1.6× Vanda Pharmaceuticals Inc.). AerSale Corp runs the higher net margin — 5.9% vs -246.8%, a 252.7% gap on every dollar of revenue. On growth, Vanda Pharmaceuticals Inc. posted the faster year-over-year revenue change (7.6% vs -4.0%). AerSale Corp produced more free cash flow last quarter ($9.8M vs $-29.5M). Over the past eight quarters, Vanda Pharmaceuticals Inc.'s revenue compounded faster (9.8% CAGR vs 0.2%).
AerSale, Inc. is a Doral, Florida-based global supplier of aftermarket commercial jet aircraft, engines, used materials, and aeronautical engineering services to passenger and cargo airlines, government, multinational original equipment manufacturers, and independent MROs. AerSale is a member of the Aircraft Fleet Recycling Association.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its key marketed products cover indications including sleep-wake cycle disturbances and schizophrenia, with core operations and primary sales markets concentrated in North America, catering to patient groups with significant unmet medical needs.
ASLE vs VNDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $90.9M | $57.2M |
| Net Profit | $5.4M | $-141.2M |
| Gross Margin | 34.1% | — |
| Operating Margin | 7.8% | -70.5% |
| Net Margin | 5.9% | -246.8% |
| Revenue YoY | -4.0% | 7.6% |
| Net Profit YoY | 99.7% | -2774.3% |
| EPS (diluted) | $0.10 | $-2.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $90.9M | $57.2M | ||
| Q3 25 | $71.2M | $56.3M | ||
| Q2 25 | $107.4M | $52.6M | ||
| Q1 25 | $65.8M | $50.0M | ||
| Q4 24 | $94.7M | $53.2M | ||
| Q3 24 | $82.7M | $47.7M | ||
| Q2 24 | $77.1M | $50.5M | ||
| Q1 24 | $90.5M | $47.5M |
| Q4 25 | $5.4M | $-141.2M | ||
| Q3 25 | $-120.0K | $-22.6M | ||
| Q2 25 | $8.6M | $-27.2M | ||
| Q1 25 | $-5.3M | $-29.5M | ||
| Q4 24 | $2.7M | $-4.9M | ||
| Q3 24 | $509.0K | $-5.3M | ||
| Q2 24 | $-3.6M | $-4.5M | ||
| Q1 24 | $6.3M | $-4.1M |
| Q4 25 | 34.1% | — | ||
| Q3 25 | 30.2% | — | ||
| Q2 25 | 32.9% | — | ||
| Q1 25 | 27.3% | — | ||
| Q4 24 | 31.4% | — | ||
| Q3 24 | 28.6% | — | ||
| Q2 24 | 28.2% | — | ||
| Q1 24 | 31.8% | — |
| Q4 25 | 7.8% | -70.5% | ||
| Q3 25 | 4.0% | -55.6% | ||
| Q2 25 | 11.7% | -73.2% | ||
| Q1 25 | -10.1% | -82.0% | ||
| Q4 24 | 5.2% | -19.3% | ||
| Q3 24 | 2.4% | -23.1% | ||
| Q2 24 | -2.4% | -20.1% | ||
| Q1 24 | 5.2% | -19.5% |
| Q4 25 | 5.9% | -246.8% | ||
| Q3 25 | -0.2% | -40.1% | ||
| Q2 25 | 8.0% | -51.7% | ||
| Q1 25 | -8.0% | -58.9% | ||
| Q4 24 | 2.9% | -9.2% | ||
| Q3 24 | 0.6% | -11.2% | ||
| Q2 24 | -4.7% | -9.0% | ||
| Q1 24 | 6.9% | -8.7% |
| Q4 25 | $0.10 | $-2.40 | ||
| Q3 25 | $0.00 | $-0.38 | ||
| Q2 25 | $0.18 | $-0.46 | ||
| Q1 25 | $-0.10 | $-0.50 | ||
| Q4 24 | $0.05 | $-0.09 | ||
| Q3 24 | $0.01 | $-0.09 | ||
| Q2 24 | $-0.07 | $-0.08 | ||
| Q1 24 | $0.12 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.4M | $84.9M |
| Total DebtLower is stronger | $1.3M | — |
| Stockholders' EquityBook value | $424.4M | $327.2M |
| Total Assets | $640.5M | $488.9M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.4M | $84.9M | ||
| Q3 25 | $5.3M | $70.0M | ||
| Q2 25 | $5.7M | $81.0M | ||
| Q1 25 | $4.7M | $111.8M | ||
| Q4 24 | $4.7M | $102.3M | ||
| Q3 24 | $9.8M | $100.5M | ||
| Q2 24 | $4.3M | $103.0M | ||
| Q1 24 | $2.6M | $125.2M |
| Q4 25 | $1.3M | — | ||
| Q3 25 | $1.5M | — | ||
| Q2 25 | $907.0K | — | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $1.2M | — | ||
| Q3 24 | $376.0K | — | ||
| Q2 24 | $522.0K | — | ||
| Q1 24 | $3.5M | — |
| Q4 25 | $424.4M | $327.2M | ||
| Q3 25 | $417.1M | $466.0M | ||
| Q2 25 | $415.9M | $486.3M | ||
| Q1 25 | $406.5M | $511.4M | ||
| Q4 24 | $455.6M | $538.5M | ||
| Q3 24 | $451.5M | $541.2M | ||
| Q2 24 | $449.8M | $542.5M | ||
| Q1 24 | $452.0M | $544.0M |
| Q4 25 | $640.5M | $488.9M | ||
| Q3 25 | $646.3M | $601.1M | ||
| Q2 25 | $646.7M | $624.7M | ||
| Q1 25 | $646.1M | $631.9M | ||
| Q4 24 | $604.7M | $656.2M | ||
| Q3 24 | $601.5M | $645.1M | ||
| Q2 24 | $598.7M | $651.4M | ||
| Q1 24 | $571.7M | $652.7M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.4M | $-29.4M |
| Free Cash FlowOCF − Capex | $9.8M | $-29.5M |
| FCF MarginFCF / Revenue | 10.8% | -51.6% |
| Capex IntensityCapex / Revenue | 1.7% | 0.2% |
| Cash ConversionOCF / Net Profit | 2.11× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-29.1M | $-110.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.4M | $-29.4M | ||
| Q3 25 | $-8.9M | $-31.6M | ||
| Q2 25 | $19.8M | $-15.3M | ||
| Q1 25 | $-45.2M | $-33.1M | ||
| Q4 24 | $37.5M | $-1.8M | ||
| Q3 24 | $10.4M | $-14.6M | ||
| Q2 24 | $-15.3M | $-6.9M | ||
| Q1 24 | $-21.5M | $7.6M |
| Q4 25 | $9.8M | $-29.5M | ||
| Q3 25 | $-9.8M | $-31.8M | ||
| Q2 25 | $18.6M | $-15.6M | ||
| Q1 25 | $-47.6M | $-33.6M | ||
| Q4 24 | $32.3M | $-2.0M | ||
| Q3 24 | $8.9M | $-14.7M | ||
| Q2 24 | $-18.9M | $-7.0M | ||
| Q1 24 | $-25.0M | $7.6M |
| Q4 25 | 10.8% | -51.6% | ||
| Q3 25 | -13.8% | -56.5% | ||
| Q2 25 | 17.3% | -29.6% | ||
| Q1 25 | -72.4% | -67.1% | ||
| Q4 24 | 34.0% | -3.8% | ||
| Q3 24 | 10.7% | -30.9% | ||
| Q2 24 | -24.6% | -13.9% | ||
| Q1 24 | -27.7% | 15.9% |
| Q4 25 | 1.7% | 0.2% | ||
| Q3 25 | 1.3% | 0.3% | ||
| Q2 25 | 1.1% | 0.6% | ||
| Q1 25 | 3.7% | 0.9% | ||
| Q4 24 | 5.6% | 0.4% | ||
| Q3 24 | 1.9% | 0.3% | ||
| Q2 24 | 4.7% | 0.2% | ||
| Q1 24 | 3.9% | 0.0% |
| Q4 25 | 2.11× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.31× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 13.89× | — | ||
| Q3 24 | 20.52× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -3.42× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASLE
| Products | $57.8M | 64% |
| Maintenance | $23.2M | 26% |
| Leasing Arrangements | $9.9M | 11% |
VNDA
| Fanapt | $33.2M | 58% |
| Hetlioz | $16.4M | 29% |
| PONVORY | $7.6M | 13% |
